Updates on the Management of Cervical Cancer

Zahra Ghiassi-Nejad, MD, PhD, Theresa Shao, MD, and Konstantin Zakashansky, MD, discuss updates in the management of patients with cervical cancer. The conversation includes treatment options for early stage versus locally advanced disease, updates in surgery and radiation, and the future of systemic therapy.

FICO 2018: changes to staging criteria

In the first segment of this roundtable discussion, Dr. Ghiassi-Nejad and Dr. Zakashansky discuss the salient changes for cervical cancer as proposed by FIGO in 2018.

Up Next

FICO 2018: changes to staging criteria
Treatment for early-stage versus locally advanced cervical cancer
What does the LACC trial mean for minimally-invasive surgery?
Is minimally invasive surgery still an option?
Updates in radiation for cervical cancer
Updates in systemic therapies for cervical cancer
Immunotherapy for cervical cancer
HPV vaccine and T cell therapy

About the Panel

Zahra Ghiassi-Nejad, MD, PhD

  • Ican School of Medicine at
  • Mount Sinai
  • New York

Theresa Shao, MD

  • Ican School of Medicine at
  • Mount Sinai
  • New York

Konstantin Zakashansky, MD

  • Icahn School of Medicine at
  • Mount Sinai
  • New York
Disclosures

The faculty received modest honoraria from Frontline Medical Communications for their participation in this roundtable. The faculty have no conflicts of interest to disclose.